C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis.

CONCLUSIONS: The current evidence indicated that c-Met over expression is significantly associated with a poorer prognosis in EC. C-Met may serve as a potential novel prognostic biomarker for EC patients. PMID: 27636117 [PubMed - as supplied by publisher]
Source: Panminerva Medica - Category: Journals (General) Tags: Panminerva Med Source Type: research